A Phase III Randomized Study of Zolendronate Bisphosphonate Therapy for the Prevention of Bone Loss in Men With Prostate Cancer Receiving Long-Term Androgen Deprivation.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 20 Mar 2017
At a glance
- Drugs Calcium gluconate; Colecalciferol; Zoledronic acid
- Indications Male osteoporosis
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 15 Mar 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2020.
- 15 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2018.